![[Val20] - HPV 16 E7 (11 - 19)](/media/com_eshop/products/resized/prod_150x150-500x500.png "[Val20] - HPV 16 E7 (11 - 19)")
Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
[Val20] - HPV 16 E7 (11 - 19)
| Overview | |
|---|---|
| Description | This peptide is a modified human papilloma virus (HPV) type 16 oncoprotein E7-derived cytotoxic T lymphocyte (CTL) epitope. This modified epitope has higher affinity for HLA-A2.1 and increased immunogenicity. Thus, this peptide may be useful in the development of vaccine against HPV16-induced cervical carcinoma. |
| Sequence | YMLDLQPETV |
| Sequence (3 Letter) | H-Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Val-OH |
| Molecular Weight | 1208.4 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Schreurs, M. et al. Vaccine 23, 4005 (2005)
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.